| Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany C Lübbert, L Straube, C Stein, O Makarewicz, S Schubert, J Mössner, ... International Journal of Medical Microbiology 305 (1), 148-156, 2015 | 213 | 2015 |
| Environmental pollution with antimicrobial agents from bulk drug manufacturing industries in Hyderabad, South India, is associated with dissemination of extended-spectrum beta … C Lübbert, C Baars, A Dayakar, N Lippmann, AC Rodloff, M Kinzig, ... Infection 45 (4), 479-491, 2017 | 200 | 2017 |
| Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a … C Lübbert, S Faucheux, D Becker-Rux, S Laudi, A Dürrbeck, T Busch, ... International journal of antimicrobial agents 42 (6), 565-570, 2013 | 156 | 2013 |
| Clostridium difficile infection: guideline-based diagnosis and treatment C Lübbert, E John, L von Müller Deutsches Ärzteblatt International 111 (43), 723, 2014 | 137 | 2014 |
| Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control … C Lübbert, D Becker-Rux, AC Rodloff, S Laudi, T Busch, M Bartels, ... Infection 42, 309-316, 2014 | 131 | 2014 |
| Therapy of liver abscesses C Lübbert, J Wiegand, T Karlas Viszeralmedizin 30 (5), 334-341, 2014 | 127 | 2014 |
| Long-term carriage of Klebsiella pneumoniae carbapenemase–2-producing K pneumoniae after a large single-center outbreak in Germany C Lübbert, N Lippmann, T Busch, UX Kaisers, T Ducomble, T Eckmanns, ... American journal of infection control 42 (4), 376-380, 2014 | 124 | 2014 |
| The diagnosis and treatment of pinworm infection S Wendt, H Trawinski, S Schubert, AC Rodloff, J Mössner, C Lübbert Deutsches Ärzteblatt International 116 (13), 213, 2019 | 115 | 2019 |
| Antimicrobial therapy of acute diarrhoea: a clinical review C Lübbert Expert review of anti-infective therapy 14 (2), 193-206, 2016 | 78 | 2016 |
| S2k-guideline gastrointestinal infectious diseases and Whipple's disease. S Hagel, HJ Epple, GE Feurle, WV Kern, PL Jansen, P Malfertheiner, ... | 65 | 2015 |
| Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis PA Reuken, D Torres, M Baier, B Löffler, C Lübbert, N Lippmann, ... PloS one 12 (1), e0169900, 2017 | 62 | 2017 |
| Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents: a prospective cohort study C Lübbert, K Wendt, J Feisthammel, A Moter, N Lippmann, T Busch, ... PLoS One 11 (5), e0155479, 2016 | 58 | 2016 |
| Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis C Lübbert, L Zimmermann, J Borchert, B Hörner, R Mutters, AC Rodloff Infectious diseases and therapy 5, 545-554, 2016 | 57 | 2016 |
| Autochthonous West Nile virus infection outbreak in humans, Leipzig, Germany, August to September 2020 C Pietsch, D Michalski, J Münch, S Petros, S Bergs, H Trawinski, ... Eurosurveillance 25 (46), 2001786, 2020 | 54 | 2020 |
| Fecal microbiota transplant in patients with recurrent Clostridium Difficile infection: a retrospective multicenter observational study from the microtrans registry S Hagel, A Stallmach, M Vehreschild Deutsches Ärzteblatt international 113 (35-36), 583, 2016 | 53 | 2016 |
| Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction T Ducomble, S Faucheux, U Helbig, UX Kaisers, B König, A Knaust, ... Journal of Hospital Infection 89 (3), 179-185, 2015 | 53 | 2015 |
| Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial MN Polizzotto, J Nordwall, AG Babiker, A Phillips, DM Vock, N Eriobu, ... The Lancet 399 (10324), 530-540, 2022 | 50 | 2022 |
| Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort A Rockstroh, J Wolf, J Fertey, S Kalbitz, S Schroth, C Lübbert, S Ulbert, ... Emerging microbes & infections 10 (1), 774-781, 2021 | 44 | 2021 |
| Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia S Ny, R Kozlov, U Dumpis, P Edquist, K Gröndahl-Yli-Hannuksela, ... European journal of clinical microbiology & infectious diseases 37, 2347-2354, 2018 | 35 | 2018 |
| A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients R Wendt, L Thijs, S Kalbitz, H Mischak, J Siwy, J Raad, J Metzger, ... EClinicalMedicine 36, 2021 | 34 | 2021 |
